Comprehensive Fungal Detection Without Uncertainty
Fungifast® uses next-generation sequencing and proprietary algorithms to identify clinically relevant fungal pathogens with speed and precision. Designed for acute, chronic, and immunocompromised patient populations, it delivers diagnostic clarity when fungal infections are difficult to detect or differentiate.
Fungifast®
Complete Fungal Detection
Fungifast® is a CE-IVDR certified pan-fungal identification solution powered by the Credence Genomics pathogen detection stack, using long-read sequencing combined with machine learning to enable comprehensive fungal detection with confidence.
Designed for critical and complex fungal infections, Fungifast® enables rapid, culture-independent identification of over 6,000 fungal organisms at genus and species level delivering clear, actionable insights within 24 hours. It is a deployable molecular diagnostic platform designed for hospitals and laboratories managing high-risk infections.
Conventional fungal diagnostics are slow, insensitive, and often inconclusive. Using our proprietary platform, sequencing data is transformed into meaningful, reproducible signals, providing precise and absolute resolution in fungal infections. From ICU-acquired invasive mycoses to routine diagnostic challenges, Fungifast® supports clinicians by eliminating uncertainty and enabling timely intervention.
Bactfast® integrates seamlessly with other detection kits:
Request Product Access
Clinical Applications
Fungifast® is commonly used in high-risk and diagnostically complex scenarios, and is especially valuable when traditional fungal culture, PCR, or serology are negative, delayed, or inconclusive. Those scenarios include:
Suspected invasive fungal infections
ICU and critically ill patients
Immunocompromised patients (oncology, transplant)
Non-resolving infections with negative cultures
Co-infection with bacterial pathogens
Situations requiring rapid diagnostic clarity
The Challenge
The Limitations of Traditional Fungal Diagnostics
Delays in obtaining results can postpone targeted treatment, increasing the risk of complications in critical patients.
When infections go undetected by traditional methods, clinicians face diagnostic uncertainty that can compromise timely care.
Tests that miss less common or slow-growing organisms may result in incomplete diagnoses, hindering effective treatment decisions.
Tests that miss less common or slow-growing organisms may result in incomplete diagnoses, hindering effective treatment decisions.
The SOLUTION
How Fungifast® Delivers Diagnostic Clarity
Fungifast® uses next-generation sequencing and proprietary bioinformatics to rapidly identify fungal pathogens with high specificity. Designed for complex and chronic cases, it delivers a complete diagnostic picture when traditional testing is inconclusive.
Metric | Fungi® | Fungal Culture | Fungal PCR Panels | Insight |
|---|---|---|---|---|
Detection Approach
| Targeted metagenomic sequencing (ITS1 / ITS2) | Growth-based | Targeted amplification | Unbiased sequencing avoids organism pre-selection |
Organism Coverage
| 6,000+ fungal species | Limited (common, culturable fungi) | Limited (panel-restricted) | Broad-spectrum detection in a single test |
Culture-Independent Detection
| Yes | No | Yes | Effective even after antifungal therapy |
Detection in Culture-Negative Infections | High | None | Variable | Identifies infections missed by culture |
Mixed/Co-Infections | Clearly detected | Often missed | Partially detected | Resolves complex fungal-bacterial landscapes |
Species-Level Resolution
| High (genus & species) | Variable | Variable | Enables confident clinical interpretation |
Turnaround Time
| <24 hours | 5–14 days | 12 – 24 hours | Faster results enable earlier intervention |
Sensitivity in Invasive Disease
| High | Low–moderate | Moderate | Improved detection in low fungal burden |
Connect with Credence Genomics to learn more about our Fungal Pathogen Stack.
Precision Fungal Diagnostics for Complex Clinical Cases
Fungifast® equips clinicians with reliable insights into fungal infections that are often missed or delayed by conventional testing. With broad species coverage, faster turnaround, and precise differentiation between colonization and infection, it supports timely, evidence-based antifungal treatment decisions in high-risk patient populations.
Accuracy of Pathogen Detection
Read More About Our Research.
Our Process
How Credence Genomics Detection Kits Work
Clinical samples are processed using validated wet-lab protocols designed to preserve microbial DNA while minimizing contamination. This ensures consistent, high-quality input across diverse sample types.
Next-generation sequencing captures the full microbial landscape within each sample. Proprietary bioinformatics and machine learning algorithms identify pathogens while separating commensal organisms and contaminants.
Results are delivered in a clear, structured format—providing species-level identification and clinically relevant insights that support informed treatment decisions and faster patient care for your needs.